Sign in

CIK 0001104506

  • Large accelerated filer
Ticker
INSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
Operating
EIN
541972729
Phone
+1 908-977-9900
Business address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,100,000
in 1 filing

Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Brennan David R −$3.1M Director sold 39% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-07 Wise John Drayton Chief Commercial Officer Exercise or conversion 10b5-1 +10,000 $16.07 $161K 132,492
2025-01-07 Wise John Drayton Chief Commercial Officer Sale 10b5-1 −10,000 $65.98 $660K 122,492
2025-01-07 Wise John Drayton Chief Commercial Officer Sale 10b5-1 −2,908 $65.87 $192K 119,584
2025-01-07 Wise John Drayton Chief Commercial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −10,000 0
2025-01-07 Lewis William Chair and CEO Sale −8,218 $66.02 $543K 376,742
2025-01-07 Smith Michael Alexander Chief Legal Officer Sale −2,306 $65.98 $152K 65,642
2025-01-07 Adsett Roger Chief Operating Officer Sale 10b5-1 −2,444 $65.95 $161K 147,666
2025-01-02 Lewis William Chair and CEO Exercise or conversion 10b5-1 +18,750 $22.76 $427K 403,710
2025-01-02 Lewis William Chair and CEO Sale 10b5-1 −18,750 $69.84 $1.3M 384,960
2025-01-02 Lewis William Chair and CEO Exercise or conversion 10b5-1 +6,830 $10.85 $74K 240,754
2025-01-02 Lewis William Chair and CEO Sale 10b5-1 −6,830 $69.86 $477K 233,924
2025-01-02 Lewis William Chair and CEO Exercise or conversion · Stock Option (right to buy) 10b5-1 −18,750 93,750
2025-01-02 Lewis William Chair and CEO Exercise or conversion · Stock Option (right to buy) 10b5-1 −6,830 225,460
2024-12-19 Lewis William Chair and CEO Exercise or conversion 10b5-1 +18,750 $22.76 $427K 403,710
2024-12-19 Lewis William Chair and CEO Sale 10b5-1 −13,162 $69.65 $917K 390,548
2024-12-19 Lewis William Chair and CEO Sale 10b5-1 −5,588 $70.52 $394K 384,960
2024-12-19 Lewis William Chair and CEO Exercise or conversion 10b5-1 +6,830 $10.85 $74K 240,754
2024-12-19 Lewis William Chair and CEO Sale 10b5-1 −5,240 $69.71 $365K 235,514
2024-12-19 Lewis William Chair and CEO Sale 10b5-1 −1,590 $70.61 $112K 233,924
2024-12-19 Lewis William Chair and CEO Exercise or conversion · Stock Option (right to buy) 10b5-1 −18,750 112,500

Page 34 of 42 · 826 trades